SecBot SecBot
SECBOTREPLAY Home › Report › ARTV

ARTV · RA Capital Management, a 10% owner and director, purchased a total of…

Artiva Biotherapeutics, Inc. · INSIDER-BUY filed Jul 23, 2026 at 21:22 ET

At the news

BULLISHIMPACT 7/10

INSIDER-BUY filed Jul 23, 2026 at 21:22 ET

RA Capital Management, a 10% owner and director, purchased a total of ~281K shares of Artiva Biotherapeutics for ~$2.58M across three open-market buys from July 14-21, 2026. This follows a separate cluster of RA Capital purchases totaling ~$2.58M in the prior week (July 21-23), bringing the combined insider buying to ~$5.2M over a ~10-day period. At a $248M market cap, this represents ~2.1% of the company, a highly material signal from a sophisticated healthcare investor with board representation, indicating strong conviction ahead of a potential catalyst.

  • RA Capital Management (Director, 10% Owner) purchased ~281K shares for ~$2.58M across three open-market buys from July 14-21, 2026.
  • Combined with a separate cluster of RA Capital purchases from July 21-23 (~$2.58M), total insider buying over ~10 days is ~$5.2M.
  • Total insider buying represents ~2.1% of ARTV's $248M market cap, exceeding the >2% threshold for highly material insider activity.
  • RA Capital is a sophisticated healthcare-focused investment firm with board representation, amplifying the signal's credibility.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access